Thursday, August 25, 2016

BRIEF-Hemispherx Biopharma received approval of its new drug application from ANMAT

* Received approval of its new drug application from anmat

for commercial sale of rintatolimod in argentine republic

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)